Yuhan Corporation (KRX:000100)

Market Cap	7.45T -18.7%
Revenue (ttm)	2.19T +6.4%
Net Income	194.08B -59.4%
EPS	2,599.51 -60.0%
Shares Out	74.44M
PE Ratio	38.58
Forward PE	47.13
Dividend	500.00 (0.50%)
Ex-Dividend Date	Feb 26, 2026

Volume	311,773
Average Volume	358,432
Open	98,900
Previous Close	98,700
Day's Range	98,700 - 100,600
52-Week Range	91,600 - 137,800
Beta	0.48
RSI	44.75
Earnings Date	May 15, 2026

About Yuhan

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperl...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1926
• Employees: 2,067
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 000100

Financial Performance

In 2024, Yuhan's revenue was 2.07 trillion, an increase of 11.23% compared to the previous year's 1.86 trillion. Earnings were 69.59 billion, a decrease of -48.90%.